Bharat Biotech’s COVID-19 nasal vaccine phase 3 trials completed

On Saturday (local time), Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, said that the clinical phase III trials of the COVID-19 nasal vaccination were finished and that the business will submit its data to the Drugs Controller General of India (DCGI) next month.

In an exclusive interview with ANI, Dr Ella said, “We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine.”

Krishna was speaking at Viva Technology 2022 in Paris, where India was named nation of the year.

Bharat Biotech was granted authorization to perform independent phase III studies on its COVID-19 nasal vaccination by India’s drug controller in January of this year.

Krishna stated that people who have taken the second dosage of COVID-19 must also take the booster dose.

“Booster dose of vaccine gives immunity. I always say the booster dose is a miracle dose for every vaccination. Even in children first, two doses don’t give much immunity, but the third dose gives an amazing response to the child. The same thing for adults also. The third dose is very important for adults. COVID-19 can’t be eradicated 100 per cent. It will be there and we have to live with it and handle it and more intelligently how to control it,” he said.

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France.

“I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997.”
He said that earlier United States was the centre of startups but for the first time Indians are getting exposure in France.

Also Read: Mouse study reveals intense exercise could suppress your appetite

“I am so happy to say the French government is very practical. They are really encouraging India and with truthfully a good heart. Again, they are really pushing how more the government can work together. How about the country’s startups can work together? How government policies can create an ecosystem that is scalable, even French President Macron was talking about how to scale it up between the two partnerships, how to scale up for globe and the digitalization all that is talking about infrastructure, digitalization all that they are talking and that is a good sign between the two countries and the first time French is coming closer to India,” he added.

Follow Medically Speaking on Instagram